By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Science Briefing

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - This weeks’ Science Briefing of Infectious Diseases science

Medicine

This weeks’ Science Briefing of Infectious Diseases science

Last updated: June 29, 2026 10:09 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE
Subject: Asia-Wide Clinical Trials Network Takes on Antimicrobial Resistance

Science Briefing

Personalized briefing

Top 5 discoveries  ·  Infectious Diseases

Advancing Clinical Evidence in Infectious Diseases: An Infectious Diseases Clinical Trials Network for Asia, the “Antimicrobial Resistance Hot Zone”

Dear Nikita Devnarain — this week’s five most relevant discoveries, curated for your work in Infectious Diseases.

Key findings

Medicine · Infectious Diseases

No. 1

The ADVANCE-ID network has established a pan-Asian clinical trials infrastructure encompassing more than 100 hospitals to generate randomized controlled trial evidence for managing serious antimicrobial-resistant infections. Since 2022, the network has enrolled over 12,000 patients across Asia and is actively expanding research sites into Africa, the Middle East, and Latin America to address the global burden of drug-resistant bacterial infections. For your work on HIV-TB co-infection and AIDS-related comorbidities, this network’s focus on generating high-quality evidence for antimicrobial-resistant infections in LMICs directly supports the clinical trial infrastructure needed to evaluate new treatment and prevention strategies in high-burden settings.

Novelty

85%

Rigor

88%

Significance

92%

Validity

86%

Clarity

90%


Read the paper →

Medicine · Infectious Diseases

No. 2

Antimicrobial stewardship in LMICs: from paper promises to purpose-driven people

Antimicrobial stewardship programs in low- and middle-income countries are failing not because of inadequate policies but because of a critical shortage of trained, locally embedded stewards who can adapt interventions to real-world constraints. The authors argue that sustainable progress against antimicrobial resistance depends on investing in mentored, purpose-driven local professionals and empowering multidisciplinary teams to implement context-appropriate stewardship strategies. Given your focus on HIV-TB treatment and public health in high-burden settings, this emphasis on building local stewardship capacity is directly relevant to preserving the efficacy of antiretroviral and anti-TB therapies where resistance threatens treatment outcomes.

Novelty

82%

Rigor

86%

Significance

88%

Validity

84%

Clarity

91%


Read the paper →

Medicine · Infectious Diseases

No. 3

Inconsistent Strategies to Mitigate the Effects of Batrachochytrium salamandrivorans, Europe

A new analysis documents inconsistent mitigation strategies across European countries for addressing the emerging amphibian pathogen Batrachochytrium salamandrivorans, which threatens salamander biodiversity. The study identifies gaps in surveillance, biosecurity, and response coordination that undermine regional efforts to contain the spread of this highly virulent fungal pathogen. While this pathogen does not directly affect human populations, the principles of coordinated surveillance and response to emerging infectious threats are transferable to your work on pandemic preparedness and COVID-19 epidemiology.

Novelty

74%

Rigor

80%

Significance

65%

Validity

78%

Clarity

76%


Read the paper →

Medicine · Infectious Diseases

No. 4

[Obituary] Dame Bridget Ogilvie

Dame Bridget Ogilvie, a pioneering parasitologist and former Director of the Wellcome Trust, has died at age 88, leaving a legacy in global health advocacy and research funding. Her leadership at the Wellcome Trust transformed the organization into one of the world’s most influential funders of biomedical research, with particular emphasis on infectious diseases and global health. For your research on HIV/AIDS and related comorbidities, Ogilvie’s career exemplifies the impact of sustained investment in infectious disease research and the importance of advocacy for global health funding.

Novelty

55%

Rigor

68%

Significance

62%

Validity

72%

Clarity

78%


Read the paper →

Medicine · General

No. 5

Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain Research Summary

A new study compared self-directed cognitive behavioral therapy for chronic pain with asynchronous audio-recorded personalized feedback against usual clinical care to determine whether a less resource-intensive approach can effectively reduce pain. The trial assessed whether patient-directed CBT with personalized feedback could achieve meaningful outcomes comparable to traditional clinician-delivered therapy for chronic pain management. While not directly related to infectious diseases, the methodological approach of comparing self-directed versus clinician-delivered interventions may inform your work on scalable HIV prevention and treatment adherence interventions in resource-limited settings.

Novelty

70%

Rigor

84%

Significance

60%

Validity

80%

Clarity

82%


Read the paper →

Advertisement

ScientificChina — verified Chinese lab & medical equipment suppliers, direct. Browse suppliers →


Update preferences →


Give feedback →

Your briefing is personalized based on your selected fields, keywords, and research interests.  

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article This weeks’ Science Briefing of Oncology science
Next Article Science Briefing
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

The Stomach’s pH: A New Frontier in Anesthetic Drug Delivery

Science Briefing

Science Briefing

Today’s Neurology Science Briefing | April 3rd 2026, 9:00:31 am

This week’s Medicine Key Highlights

The Molecular Blueprint of Social Withdrawal

Ocular Lyme, revisited: what decades of cases reveal

Science Briefing

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Natural Language Processing
  • Chemistry
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?